Managing Antibiotic Resistance

Antibiotics or no antibiotics? How to prevent HAIs and the spread of bacterial resistance? Do you need to reinforce your environmental control measures?

bioMérieux can help you meet the daily challenges of fighting antibiotic resistance in your workplace.

Antibiotic resistance is now recognized worldwide as a major healthcare threat. Faced with the increasing emergence and spread of MDROs and the lack of new antibiotics, healthcare providers need effective tools - and actionable results – to face the resistance challenge every day.

Relevant antibiotic prescribing

Up to 50% of antibiotics are prescribed unnecessarily or are not optimally effective as prescribed.1,2

Today, fast diagnostic tests can help you make the right decision for antibiotic treatment.

For example: Antibiotics or no antibiotics ?

Procalcitonin (PCT) levels correlate with presence and severity of bacterial infection, providing useful, within-the-hour guidance on when to initiate and/or adjust antibiotic therapy, as well as when to continue/stop treatment earlier.3

In just 5-10 minutes, Strep A or Influenzarapid tests can help physicians prescribe antibiotics only when necessary and reduce the spread of bacterial resistance.

Today, you can get same-day identification and susceptibility test (ID/AST) results to help you prescribe the right antibiotic for the right patient.

For example: Same-day results for relevant antibiotic therapy

Cutting the traditional time-to-result for bacterial ID by hours, MALDI-TOF MS* technology enables accurate identification of microorganism species within minutes. Then susceptibility testing systems take over to determine and interpret susceptibility results in as little as 5-8 hours4, ensuring that the most relevant antibiotic is prescribed. (Read more »).

“In our institution, [faster reporting of susceptibility results] has made a huge impact on patient care. The clinicians, especially in Infectious Diseases, now know that when they make their rounds in the afternoon, new data on their patients are already available.”

​Reduce the time needed to detect and treat C. difficile infections by choosing a global diagnostic solution that covers automated first-line GDH testing and toxin EIA immunoassays, as well as culture and molecular tests. Comply with the most recent guidelines, which recommend the use of a two- or three-step protocol for optimal patient treatment and management.5,6

With extensive expertise in microbiology and susceptibility testing, bioMérieux has a long-term commitment to fighting antibiotic resistance. We work closely with our healthcare partners to provide solutions that can help you manage antibiotic resistance more efficiently.

** VIDAS® B.R.A.H.M.S PCT™ supports the clinical management of sepsis, and procalcitonin cut-off thresholds are an aid to the clinical management of lower respiratory tract infections, but under no circumstances replace clinical judgment and thorough clinical assessment of patients.